Nagafuchi et al. (2015) claimed that the TYK2 promoter variant was associated with a more significant increased T1D risk in individuals with flu-like syndrome and in anti-GAD antibody-negative patients, but not in those with positive anti-GAD antibody. The gene discussed is TYK2; the disease is type 1 diabetes mellitus.